Related Experiment Videos
Microbiota-regulated TCDCA associates with Parkinson's disease severity and promotes BBB dysfunction through VSMC
Zhe Zhao1, Yixuan Liu2, Wen Ma3
1Department of Pharmacy, Peking University Third Hospital, Beijing 100191, China; Institute for Drug Evaluation, Peking University Health Science Center, Beijing 100191, China.
Abstract:
Parkinson's disease (PD) is a systemic disorder linked to gut dysbiosis, yet key microbiota-regulated metabolites remain unclear. Here, we observe elevated taurochenodeoxycholic acid (TCDCA) in patients with PD that correlates with disease severity. Reduced bile salt hydrolase (BSH) gene abundance correlates inversely with circulating TCDCA, consistent with altered bile acid deconjugation. Exogenous TCDCA correlates with aggravated motor and gastrointestinal deficits, impaired blood-brain barrier (BBB) integrity, and accelerated dopaminergic neurodegeneration in a PD mouse model. Mechanistically, TCDCA links to TGR5 signaling activation in vascular smooth muscle cells (VSMCs), alongside PKCα-dependent mitochondrial apoptosis and BBB disruption. VSMC-specific Tgr5 deletion coincides with neurovascular protection. Supplementation with a BSH-high Lactobacillus reuteri strain reduces TCDCA concentrations, improves gut and BBB integrity, mitigates inflammation, and alleviates PD-like phenotypes in a BSH-dependent manner. These data support a gut-BBB-brain axis linked to PD, identifying TCDCA as a candidate pathological marker.
Related Concept Videos
Parkinson Disease ll: Pathophysiology
Gut-Brain Axis
Dysbiosis of the Gut Microbiota
Microbiota Modulation by Antibiotics
Parkinson Disease l: Introduction
Neural Regulation